SDZ-62-434

• Description :

  SDZ-62-434 is a platelet-activating factor (PAF) antagonist. SDZ-62-434 has antiproliferative activity in human solid and haematological malignancies[1].

• UNSPSC :

  12352005

• Target :

  Platelet-activating Factor Receptor (PAFR)

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/sdz-62-434.html

• Solubility :

  10 mM in DMSO

• Smiles :

  [H]Cl.[H]Cl.C12=C(C=C(C3=CC=C(CN4CCCCC4)C=C3)N5C2=NCC5)C=CC=C1

• Molecular Formula :

  C23H27Cl2N3

• Molecular Weight :

  416.39

• References & Citations :

  [1]V G Brunton, et al. In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434. Br J Cancer. 1993 May;67 (5) :989-95.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 1

• CAS Number :

  [115621-95-9]